| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |